EDIT
Asset Logo

Editas Medicine Inc.

๐Ÿ‡บ๐Ÿ‡ธ NYSE/NASDAQ

Compare
Add to watchlist
๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ’ต Cost

๐Ÿƒ Esg

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

-18.03%
Annual Growth

5 years average annual growth

๐ŸŒ

2
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

Editas Medicine, Inc. is a clinical-stage genome editing company. The Company is focused on developing potentially transformative genomic medicines to treat a broad range of serious diseases. It has developed a proprietary gene editing platform based on CRISPR technology. CRISPR uses a protein- ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 (Cas9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1), bound to a guide ribonucleic acid (RNA) molecule designed to recognize a particular deoxyribonucleic acid (DNA) sequence. It is engaged in the development of vivo administered gene editing medicines, in which the medicine is injected or infused into the patient to edit the cells inside their body. Its lead program, reni-cel, is an experimental ex vivo gene-edited medicine to treat sickle cell disease (SCD), a severe inherited blood disease that causes premature death, and transfusion-dependent beta thalassemia (TDT).

๐Ÿ“ˆ Performance

Price History*

-86.56%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

N/A
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿค“ Advanced information

Technical Info

๐Ÿ’ฐ Price*

$2.41

*Price may be up to 24 hours old

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in EDIT

2

๐Ÿ“Š Total Capital Earnings

N/A

๐Ÿ”ƒ Average investment frequency

79 weeks

๐Ÿ’ต Average investment amount

$3,848

โฐ Last time a customer invested in EDIT

15 days
EDIT investor breakdown
๐Ÿ’ต Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

100%

Less than 50k

๐Ÿ‘ถ Age of investors

18 - 25

26 - 34

50%

35 - 90

50%
๐Ÿ™‹ Legal gender of investors

Female

Male

100%

Pearlers who invest in EDIT also invest in...

CRISPR Therapeutics AG

CRSP

๐Ÿ™Œ Performance (5Yr p.a)

-4.41%

๐Ÿ“Š Share price

$46.29 USD
Find Out More

๐Ÿ™Œ Performance (5Yr p.a)

2.77%

๐Ÿ“Š Share price

$12.08 USD

๐Ÿ™Œ Performance (5Yr p.a)

-11.75%

๐Ÿ“Š Share price

$24.01 USD

๐Ÿ™Œ Performance (5Yr p.a)

-4.58%

๐Ÿ“Š Share price

$127.32 USD

๐Ÿ™Œ Performance (5Yr p.a)

3.50%

๐Ÿ“Š Share price

$52.96 USD

Want more shares? Try these...

๐Ÿ™Œ Performance (5Yr p.a)

2.98%

๐Ÿ“Š Share price

$35.64 USD

๐Ÿ“Š Share price

$25.88 USD
Compare
Add to watchlist